Insights

  • Date

  • Content Type

  • Reset

Blog

Regulatory Science as an Important Principle of Good Consultancy Practices (“GCP”)

29.08.18

By Michael Pfleiderer

Regulatory science is the foundation of regulatory decision-making and is used to assess the quality, safety, and...

Read More

Blog

Advanced Therapies in Wound Management: What Needs to be Considered for an Integrated Development Strategy

17.07.18

By Diane Seimetz

The great potential of advanced therapies in wound management was recently demonstrated by a case study where...

Read More

Blog

Expediting the Development of Advanced Therapies such as CAR-T cells by making use of FDA’s RMAT designation

3.07.18

By Annegret Vaggelas

In 2017, the first CAR-T cell therapies (Kymriah, Yescarta) have been approved by FDA. End of June...

Read More

Blog

Regulating Bacteriophages: The First Steps into the Post-Antibiotic Era

19.06.18

By Luka Kotrikadze

It was in the year of 1915 when Frederic William Twort published the paper in The Lancet...

Read More

Blog

From IMPD to IND – same but different

2.03.18

By Rajeswara Rao Pannem

The aim of an investigational new drug application (IND) is to obtain approval from FDA to perform clinical trials...

Read More

Blog

A guide to scientific due diligence: How to set up an efficient process Part 1

13.02.18

By Dr. Diane Seimetz

When being asked “What is a scientific due diligence?”, what would you respond? Would you have a straightforward and...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more